Prestige Consulting - Communications and Reputation Strategies’ Post

Prestige Consulting - Communications and Reputation Strategies reposted this

What’s really driving Pharma’s reputation? 🤔 💉 Reputation is dynamic in nature, influenced by various factors that shape public perception. Our reputation wheelhouse goes beyond a single score to quantify and categorize reputation across different influencing factors. Our seven Drivers measure why people think a certain way about you, so you can act with precision to improve and protect your reputation: ✅ Products & Services ✅ Performance ✅ Leadership ✅ Innovation ✅ Workplace ✅ Conduct ✅ Citizenship According to the 2024 Pharma report, all of Pharma’s Drivers are up in H1 2024, signaling a continued recovery in public perception following the pandemic. 📈 This reputational growth highlights the industry’s commitment to transparency, innovation, and relationship-building. It’s not just about developing cutting-edge treatments — it's also about fostering ethical practices and engaging the right stakeholders. Investing in these areas isn't just about checking boxes — it’s a strategic, holistic approach to reputation management. If you’re ready to start managing your reputation, book your free demo today:  https://lnkd.in/g6pYZBJC

  • No alternative text description for this image
Mark Sonders

Chief Executive Officer & Board Director | Chief Revenue Officer Credentials

2mo

At RepTrak, we understand the unique challenges and opportunities within the pharmaceutical industry, which is why we've developed RepTrak for Pharma – a solution specifically tailored to help pharma companies navigate the complexities of their reputation across multiple stakeholders, from regulators to patients and healthcare professionals. By providing actionable insights, we empower pharma brands to enhance their reputation and drive business results in a highly regulated and ever-evolving sector. Learn more about our Pharma-specific solutions here: https://www.reptrak.com/industry/pharma/

Laurence Stellings

SVP, Head of Advisory EMEA & APAC

2mo

While the sector has challenges, this data and analysis suggests good appreciation for the work it does. Remarkable progress being made in preventing, treating and managing serious diseases.

See more comments

To view or add a comment, sign in

Explore topics